You are here: Welcome » pharmaceutical_companies » Pfizer

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
pharmaceutical_companies:pfizer [2022/12/13 12:20]
pamela [Academic Partners UCSF] 		pharmaceutical_companies:pfizer [2023/01/10 17:37] (current)
liam [Payments to Individuals]
Line 356: Line 356:
 | [[:Dawn Bowdish]]  | Research Award  | Unknown  | Funds for pneumonia research from [[:Ontario Lung Association]] and [[Pfizer]], and ASPIRE-Pfizer New Investigator Award.((Bowdish, D. M. E. (2013, February 11). //Dr. Dawn Bowdish receives a research award from the Ontario Lung Association and Pfizer Canada (and gets to attend a swanky event to receive it!).// Bowdish Lab. Retrieved December 1, 2021, from https://archive.ph/AQqx1)) ((Bowdish, D. M. E. (2011, July 3). //Dawn wins ASPIRE-Pfizer New Investigator Award.// Bowdish Lab. Retrieved December 1, 2021, from https://archive.ph/Dvre1))  | | [[:Dawn Bowdish]]  | Research Award  | Unknown  | Funds for pneumonia research from [[:Ontario Lung Association]] and [[Pfizer]], and ASPIRE-Pfizer New Investigator Award.((Bowdish, D. M. E. (2013, February 11). //Dr. Dawn Bowdish receives a research award from the Ontario Lung Association and Pfizer Canada (and gets to attend a swanky event to receive it!).// Bowdish Lab. Retrieved December 1, 2021, from https://archive.ph/AQqx1)) ((Bowdish, D. M. E. (2011, July 3). //Dawn wins ASPIRE-Pfizer New Investigator Award.// Bowdish Lab. Retrieved December 1, 2021, from https://archive.ph/Dvre1))  |
 | [[:Richard Choi]]  | Speakers Bureau/Honoraria/Consulting  | Unknown  | Disclosed during CardioVascUpdate presentation.((Verma, S., Bucci, C., Choi, R., & Gupta, A. (2020, June 12). //Navigating Vascular Protective Strategies in HighRisk Patients During the Current Era: Practical Applications.// CardioVascUpdate. https://web.archive.org/web/20210304170904/https://cardiovascupdate.ca/files/2020/CV%20Update%20Symposium-Presentation.pdf))  | | [[:Richard Choi]]  | Speakers Bureau/Honoraria/Consulting  | Unknown  | Disclosed during CardioVascUpdate presentation.((Verma, S., Bucci, C., Choi, R., & Gupta, A. (2020, June 12). //Navigating Vascular Protective Strategies in HighRisk Patients During the Current Era: Practical Applications.// CardioVascUpdate. https://web.archive.org/web/20210304170904/https://cardiovascupdate.ca/files/2020/CV%20Update%20Symposium-Presentation.pdf))  |
 +| [[:Nigel Crawford]]  | Research  | Unknown  | "Investigator on a number of epidemiological surveillance research and vaccine safety research. Funds received by employer", [[:Murdoch Children's Research Institute]] (MCRI).((//Australian Technical Advisory Group on Immunisation - Conflict of Interest.// Australia Government Department of Health and Aged Care. Retrieved October 24, 2022, from https://web.archive.org/web/20221024032912/https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf))  |
 | [[:David Fisman]]  | Honorarium  | Unknown  | Honorarium paid for advisory board meetings regarding COVID-19 related projects.((Fisman, D. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2020/10/Declaration-of-Interest_Science-Table_David-Fisman2.pdf))  |  | [[:David Fisman]]  | Honorarium  | Unknown  | Honorarium paid for advisory board meetings regarding COVID-19 related projects.((Fisman, D. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2020/10/Declaration-of-Interest_Science-Table_David-Fisman2.pdf))  | 
 | [[:Soren Gantt]]  | Grant  | Unknown  | Research grant paid to Gantt.((Lebatteux, D., Soudeyns, H., Boucoiran, I., Gantt, S., & Diallo, A. B. (2022). //Machine learning-based approach KEVOLVE efficiently identifies SARS-CoV-2 variant-specific genomic signatures.// bioRxiv. Preprint. https://doi.org/10.1101/2022.02.07.479343))  | | [[:Soren Gantt]]  | Grant  | Unknown  | Research grant paid to Gantt.((Lebatteux, D., Soudeyns, H., Boucoiran, I., Gantt, S., & Diallo, A. B. (2022). //Machine learning-based approach KEVOLVE efficiently identifies SARS-CoV-2 variant-specific genomic signatures.// bioRxiv. Preprint. https://doi.org/10.1101/2022.02.07.479343))  |
Line 626: Line 627:
 Pfizer is so transcendently theophanic that its pronouncements are the embodiment of the scientific method, as we all witnessed when the CDC Director herself understood that a CNN report of Pfizer’s proclamation of its vaccine trial’s results amounted to an official communique of eternally settled Scientific fact. Pfizer is so transcendently theophanic that its pronouncements are the embodiment of the scientific method, as we all witnessed when the CDC Director herself understood that a CNN report of Pfizer’s proclamation of its vaccine trial’s results amounted to an official communique of eternally settled Scientific fact.
 {{ :pharmaceutical_companies:pfizer_hcq_treats_covid_text_box_large.png?400|}} {{ :pharmaceutical_companies:pfizer_hcq_treats_covid_text_box_large.png?400|}}
 +
 +
 If Pfizer declares that HCQ works to treat covid - we can limit their revised catechism to late stage severe covid if you really want to be nitpicky here - then doesn’t this mean that the formerly heretical position that HCQ can treat covid is now fundamental doctrinal truth?? If Pfizer declares that HCQ works to treat covid - we can limit their revised catechism to late stage severe covid if you really want to be nitpicky here - then doesn’t this mean that the formerly heretical position that HCQ can treat covid is now fundamental doctrinal truth??
  
Back to top